← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2005Last known activity
Jan 1, 2025
Timeline
2000s
- Jun 1, 2002
FGK Clinical Research GmbH— Founded
Drugs by trial phase (46 distinct, 45 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Acute-On-Chronic Liver Failure
- Alveolar Bone Loss
- Arterial Occlusive Diseases
- Carcinoma, Pancreatic Ductal
- Communicable Diseases
- Coronavirus Infections
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Foot
- Disease
- End Stage Liver Disease
- Epidermolysis Bullosa
- Epidermolysis Bullosa Dystrophica
- Epilepsies, Partial
- Epilepsy
- Fabry Disease
- Familial Primary Pulmonary Hypertension
- Foot Ulcer
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hyperhidrosis
- Hypertension
- Infections
- Kidney Diseases
- Liver Failure
- Major Depressive Disorder
- Malaria
- Malaria, Falciparum
- Migraine Disorders
- Neoplasms
- Neuralgia
- Parasitemia
- Parasitic Diseases
- Parkinson Disease
- Peripheral Arterial Disease
- Protozoan Infections
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Skin Ulcer
- Syndrome
- Tic Disorders
- Tics
- Tourette Syndrome
- Ulcer
- Varicose Ulcer
- Virus Diseases
Recent trials (46)
- NCT06677918CollaboratorPhase 1Jan 1, 2025
- NCT06489028CollaboratorPhase 3Sep 30, 2024
- NCT06191042CollaboratorPhase 1Jan 22, 2024
- NCT06168799CollaboratorPhase 2Dec 20, 2023
- NCT06211049CollaboratorPhase 3Dec 12, 2023
- NCT05572333CollaboratorPhase 2Nov 22, 2022
- NCT05516316CollaboratorPhase 1Oct 11, 2022
- NCT05383378CollaboratorPhase 1Aug 30, 2022
- NCT05389319CollaboratorPhase 1Jun 24, 2022
- NCT05351671CollaboratorPhase 1May 23, 2022
- NCT04971161CollaboratorPhase 2Aug 18, 2021
- NCT04849390CollaboratorPhase 2Jun 29, 2021
- NCT04849390CollaboratorPhase 2Jun 29, 2021
- NCT04435379CollaboratorPhase 3Jun 30, 2020
- NCT04429919CollaboratorPhase 2Jun 30, 2020
Details
- Founded
- Munich, DE Jun 1, 2002
- Last known activity
- Jan 1, 2025
Notes
CRO